Country Garden shares rally on disputed report that Ping An was asked to buy it
By Steve Goldstein
Shares of Country Garden ended sharply higher on Wednesday after a report that the Chinese government wanted Ping An Insurance to take control of the company.
Country Garden shares (HK:2007) ended 12% higher, while Ping An (HK:2318) stock fell 5%, following the Reuters report, which cited two people sources with direct knowledge of the matter.
Ping An denied the report. "The company hereby solemnly declares that the Reuters story is untrue, and that it has not received such requests from any relevant government departments/agencies," Ping An said Wednesday.
Both Country Garden and Ping An are based in Guangdong.
Last month, Country Garden was reported to have missed an interest payment on a dollar-denominated bond.
Country Garden had 3,121 projects in Mainland China as of the end of 2022, financed by $50 billion in debt.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-08-23 0622ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters